Home Conference Coverage American Diabetes Association Scientific Sessions 2019

American Diabetes Association Scientific Sessions 2019

Effect of Continuous Glucose Monitors on Glycemic Outcomes in Young Diabetic Patients

Canagliflozin Beneficial for Type 2 Diabetes Patients with Chronic Kidney Disease

Semaglutide Could Minimize CV Events in High-risk Patients with Type 2 Diabetes

Delayed Diabetes Diagnosis Reduces CVD Risk

Dulaglutide Safe for T2D Patients with Kidney Disease

No Significant Differences in CV Outcomes for Linagliptin and Glimepiride

Are Diabetic Patients with Atherosclerotic CVD Receiving Adequate Statin Therapy?

Breaking News from ADA 2019: June 10, 2019

Teplizumab Could Delay Type 1 Diabetes Onset

Risk Factors for Heart Disease in Young T1D Patients

Load more
Subscribe to RSS